Member Exclusive

Muting mutase improves ovarian cancer drug sensitivity

Researchers at the Chinese Academy of Sciences (Shanghai, China) have revealed how new understanding of DNA repair pathways could increase the range of cancers treatable with Olaparib.

Go to the profile of RxNet
Feb 06, 2017

Please sign in or register for FREE

Register to RxNet

RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.